Literature DB >> 8536861

Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease.

M Tada1, M Ohashi, Y Shiratori, T Okudaira, Y Komatsu, T Kawabe, H Yoshida, R Machinami, K Kishi, M Omata.   

Abstract

BACKGROUND & AIMS: We and others have previously shown that the mutation of K-ras codon 12 was found in the majority of pancreatic adenocarcinomas. The mutation has also been identified in the pancreatic duct with mucous cell hyperplasia in association with chronic pancreatitis. Ductal hyperplasia is also frequently found in the pancreas free from pancreatic carcinoma or chronic pancreatitis. The aim of this study was to assess the incidence and types of mutations in hyperplastic foci in these cases.
METHODS: The nucleotide sequence of the K-ras gene at codon 12 of the DNA extracted from microdissected hyperplastic epithelium of the pancreatic duct obtained at autopsy in patients without pancreatic adenocarcinoma or chronic pancreatitis was analyzed.
RESULTS: Of 38 patients with 79 hyperplastic foci, 12 patients (with 19 hyperplastic foci) had mutations. None of the 16 normal ducts in 12 specimens had this mutation. The nucleotide sequence of the codon in 53% of ductal hyperplastic foci was TGT or AGT, both of which were not found in 30 cases of adenocarcinoma.
CONCLUSIONS: These results suggest that the ras gene mutation occurs frequently in multifocal hyperplastic foci of pancreatic duct and that the mutations may not have direct relevance to the carcinogenesis of pancreatic cancer.

Entities:  

Mesh:

Year:  1996        PMID: 8536861     DOI: 10.1053/gast.1996.v110.pm8536861

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  59 in total

Review 1.  Molecular signatures of pancreatic cancer.

Authors:  Seung-Mo Hong; Jason Y Park; Ralph H Hruban; Michael Goggins
Journal:  Arch Pathol Lab Med       Date:  2011-06       Impact factor: 5.534

2.  Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group.

Authors:  M Porta; N Malats; L Guarner; A Carrato; J Rifà; A Salas; J M Corominas; M Andreu; F X Real
Journal:  J Epidemiol Community Health       Date:  1999-11       Impact factor: 3.710

Review 3.  Molecular diagnosis of pancreatobiliary malignancies in brush cytologies of biliary strictures.

Authors:  T M Gress
Journal:  Gut       Date:  2004-12       Impact factor: 23.059

4.  K-ras mutations and allelic loss at 5q and 18q in the development of human pancreatic cancers.

Authors:  K Sugio; K Molberg; J Albores-Saavedra; A K Virmani; Y Kishimoto; A F Gazdar
Journal:  Int J Pancreatol       Date:  1997-06

5.  Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients.

Authors:  R H Hruban; P D Sturm; R J Slebos; R E Wilentz; A R Musler; C J Yeo; T A Sohn; M L van Velthuysen; G J Offerhaus
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

Review 6.  Primary malignant fibrous histiocytoma of the pancreas: a case with K-ras mutation and a review of the literature.

Authors:  Tomotaka Akatsu; Masashi Tsugita; Seiichi Ro; Kaori Kameyama; Masaki Kitajima
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

7.  High frequency of K-ras mutations in human colorectal hyperplastic polyps.

Authors:  K Otori; Y Oda; K Sugiyama; T Hasebe; K Mukai; T Fujii; H Tajiri; S Yoshida; S Fukushima; H Esumi
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

Review 8.  Biology and management of pancreatic cancer.

Authors:  Paula Ghaneh; Eithne Costello; John P Neoptolemos
Journal:  Gut       Date:  2007-08       Impact factor: 23.059

9.  KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin.

Authors:  Chanjuan Shi; Seung-Mo Hong; Phillip Lim; Hirohiko Kamiyama; Mehtab Khan; Robert A Anders; Michael Goggins; Ralph H Hruban; James R Eshleman
Journal:  Mol Cancer Res       Date:  2009-02-10       Impact factor: 5.852

10.  Autoimmune pancreatitis misdiagnosed as a tumor of the head of the pancreas.

Authors:  Eran Brauner; Jesse Lachter; Offir Ben-Ishay; Euvgeni Vlodavsky; Yoram Kluger
Journal:  World J Gastrointest Surg       Date:  2012-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.